A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/Refractory Acute Myeloid Leukemia (AML)

被引：0

作者：

Advani, Anjali S. ^{[1
]}

Cooper, Brenda ^{[2
]}

Elson, Paul ^{[3
]}

Mukherjee, Sudipto ^{[4
]}

Fensterl, Jaime ^{[5
]}

Gerds, Aaron T. ^{[6
]}

Caimi, Paolo F. ^{[2
]}

Tomlinson, Ben K. ^{[2
]}

Malek, Ehsan ^{[7
]}

Little, Jane A. ^{[8
]}

Rush, Mary Lynn ^{[9
]}

Bogati, Samjhana ^{[10
]}

Parsons, Eric ^{[9
]}

Kane, Donna ^{[11
]}

Carraway, Hetty E. ^{[4
]}

Nazha, Aziz ^{[6
]}

Hamilton, Betty K. ^{[6
]}

Sobecks, Ronald ^{[12
]}

Bevier, Barbara ^{[9
]}

Goebel, Christopher ^{[9
]}

Zimmerman, Cassie ^{[9
]}

Nielsen, Alek D. ^{[13
]}

Hirsch, Cassandra M. ^{[13
]}

Maciejewski, Jaroslaw P. ^{[13
]}

Kalaycio, Matt ^{[4
]}

deLima, Marcos ^{[14
]}

Jacobberger, James ^{[15
]}

Woost, Philip ^{[15
]}

Sekeres, Mikkael A. ^{[4
,16
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA

[2] Univ Hosp Case Med Ctr, Adult Hematol Malignancies & Stem Cell Transplant, Seidman Canc Ctr, Cleveland, OH USA

[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH USA

[4] Cleveland Clin, Taussig Canc Inst Leukemia Program, Cleveland, OH USA

[5] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH USA

[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[7] Univ Hosp Case Med Ctr, Cleveland, OH USA

[8] Case Western Reserve Univ Univ Hosp Seidman Canc, Div Hematol Oncol, Cleveland, OH USA

[9] Cleveland Clin Leukemia Program, Taussig Canc Inst, Cleveland, OH USA

[10] Cleveland Clin Taussig Canc Inst, Taussig Canc Inst Leukemia Program, Cleveland, OH USA

[11] Univ Hosp Cleveland, Seidman Canc Ctr, Cleveland, OH USA

[12] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA

[13] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH USA

[14] Univ Hosp, Adult Hematol Malignancies & Stem Cell Transplant, Seidman Canc Ctr, Cleveland, OH USA

[15] Case Western Reserve Univ, Cleveland, OH USA

[16] Cleveland Clin, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.4065.4065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4065

引用

页数：5

共 50 条

[41] A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
Pardee, Timothy S.
Anderson, Rebecca G.
Pladna, Kristin M.
Isom, Scott
Ghiraldeli, Lais P.
Miller, Lance D.
Chou, Jeff W.
Jin, Guangxu
Zhang, Wei
Ellis, Leslie R.
Berenzon, Dmitriy
Howard, Dianna S.
Hurd, David D.
Manuel, Megan
Dralle, Sarah
Lyerly, Susan
Powell, Bayard L.
CLINICAL CANCER RESEARCH, 2018, 24 (09) : 2060 - 2073
[42] Etoposide and cytarabine as an effective and safe cytoreductive regimen for relapsed or refractory acute myeloid leukemia
Nair, G.
Karmali, R.
Gregory, S. A.
Shammo, J. M.
Fung, H. C.
Jimenez, A.
Venugopal, P.
Larson, M. L.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[43] Treatment of children with relapsed acute myeloid leukemia with gemtuzumab in combination with mitoxantrone and cytarabine.
Aplenc, R
Alonzo, TA
Gerbing, R
Smith, FO
Eric, S
Arceci, RJ
BLOOD, 2005, 106 (11) : 239B - 239B
[44] Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Anderson, Rebecca
Miller, Lance D.
Isom, Scott
Chou, Jeff W.
Pladna, Kristin M.
Schramm, Nathaniel J.
Ellis, Leslie R.
Howard, Dianna S.
Bhave, Rupali R.
Manuel, Megan
Dralle, Sarah
Lyerly, Susan
Powell, Bayard L.
Pardee, Timothy S.
NATURE COMMUNICATIONS, 2022, 13 (01)
[45] Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Rebecca Anderson
Lance D. Miller
Scott Isom
Jeff W. Chou
Kristin M. Pladna
Nathaniel J. Schramm
Leslie R. Ellis
Dianna S. Howard
Rupali R. Bhave
Megan Manuel
Sarah Dralle
Susan Lyerly
Bayard L. Powell
Timothy S. Pardee
Nature Communications, 13
[46] A new combination therapy with topotecan, cytarabine and mitoxantrone in patients with refractory or relapsed acute myeloid leukemia or blast crisis of chronic myeloid leukemia.
Höchsmann, B
Griesshammer, M
Bergmann, L
BLOOD, 1999, 94 (10) : 230B - 230B
[47] MITOXANTRONE AND ETOPOSIDE (M/E) COMBINATION IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML)
BERNASCONI, C
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 279 - 280
[48] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study.
Vey, N
Kantarjian, H
Beran, M
O'Brien, S
Cortes, J
Giles, FJ
Koller, C
Estey, E
BLOOD, 1998, 92 (10) : 235A - 235A
[49] Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study
Chen, Tara L.
Estey, Elihu H.
Othus, Megan
Gardner, Kelda M.
Markle, Lauren J.
Walter, Roland B.
LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2534 - 2536
[50] High Dose Cytarabine, Mitoxantrone and L-Asparaginase (HAMA) Salvage For Relapsed Or Refractory Acute Myeloid Leukemia (AML) In The Elderly
Ahmed, Tamjeed
Holwerda, Scott
Pardee, Timothy
Isom, Scott
Lyerly, Susan
Ellis, Leslie Renee
Manuel, Megan
Dralle, Sarah
Dmitriy, Berenzon
Klepin, Heidi D.
Powell, Bayard L.
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →